Titan Medical (CVE:TMD) said last week that it hired an outside firm, EVC Group, to create and execute an investor relations program in Canada and the U.S.
The Toronto-based robot-assisted surgery company said an EVC team based in New York City and Los Angeles is managing the program.
“EVC Group has a substantial track record for creating investor relations programs that help management teams enhance valuation,” chairman & CEO John Hargrove said in prepared remarks. “The firm has particularly strong experience with emerging medical device as well as surgical robotics companies. In addition, their account team has nearly 100 years of combined healthcare industry investor relations experience as well as hundreds of healthcare industry investor relationships that will be put to work for our company. 2016 has the potential to be a very positive year for Titan Medical. We look forward to working with the EVC Group team to maximize awareness of our potential, our achievements, and our focus on building value for our shareholders.”
Titan, which raised $12 million last month in a stock-and-warrants offering, is developing the Sport surgical system. Proceeds from the round are slated for a quintet of 1st-in-human studies this year, ahead of its expected U.S. debut in mid-2017. The company unveiled its prototype device in January.